scispace - formally typeset
R

Ronald Klein

Researcher at University of Wisconsin-Madison

Publications -  1306
Citations -  163459

Ronald Klein is an academic researcher from University of Wisconsin-Madison. The author has contributed to research in topics: Population & Diabetes mellitus. The author has an hindex of 194, co-authored 1305 publications receiving 149140 citations. Previous affiliations of Ronald Klein include Los Angeles Biomedical Research Institute & Wake Forest University.

Papers
More filters

Relationship of Blood Pressure and Other Factors to Serial Retinal Arteriolar Diameter Measurements Over Time

Ronald Klein, +6 more
TL;DR: Retinal arteriolar diameter is independently associated with past and current systolic BP, calcium channel blocker use, smoking status, body mass index, and heavy drinking during 5-year intervals.
Journal ArticleDOI

Inflammatory and endothelial dysfunction markers and proteinuria in persons with type 1 diabetes mellitus.

Karine R. Sahakyan, +4 more
- 01 Jun 2010 - 
TL;DR: A role of inflammation and endothelial dysfunction as markers and contributors of the development of diabetic nephropathy in persons with type 1 diabetes mellitus is suggested.
Journal ArticleDOI

Risk for end-stage renal disease over 25 years in the population-based WESDR cohort

Tamara J. LeCaire, +4 more
- 01 Feb 2014 - 
TL;DR: In the population-based Wisconsin Epidemiologic Study of Diabetic Retinopathy (WESDR) cohort, this article examined whether a decline in the prevalence and incidence of end-stage renal disease (ESRD) was evident with increasing calendar year of type 1 diabetes diagnosis among persons followed for 25 years.
Journal ArticleDOI

Odor identification and cognitive function in the Beaver Dam Offspring Study

Carla R. Schubert, +7 more
- 17 Sep 2013 - 
TL;DR: Olfactory impairment was associated with poorer performance on cognitive function tests in a primarily middle-aged cohort and those with impairment on an odor identification test took significantly longer to complete the Trail Making Test and the Grooved Peg Board test.
Journal ArticleDOI

Benefits of Renin-Angiotensin blockade on retinopathy in type 1 diabetes vary with glycemic control.

Tasma Harindhanavudhi, +5 more
- 01 Aug 2011 - 
TL;DR: RAS blockade reduces DR progression in normotensive, normoalbuminuric type 1 diabetic patients with A1C >7.5%.